News | May 23, 2011

New Report Details the Future of Radiation Medicine

May 23, 2011 – According to a report, radiation medicine promises to be an even more effective weapon in the battle against cancer and may ultimately prove to be useful in chronic pain and neurodegenerative disorders. The report is a compendium of the 2011 Future of Radiation Medicine symposium, sponsored by Elekta. During the symposium, leading researchers and clinicians discussed how the field of radiation medicine is rapidly changing.

In the past two decades, significant advances have been made in radiation medicine with the introduction of computers, robotics and imaging systems. These tools help to sculpt radiation therapy to the precise dimensions of tumors, therefore increasing accuracy and limiting radiation exposure to surrounding healthy tissues. Nearly two-thirds of all cancer patients will receive radiation therapy during their illness.

"In the future, radiation therapy for cancer will be significantly different than today's treatments, simply because current outcomes are unsatisfactory to patients," said Robert D. Timmerman, M.D., professor and vice chair of radiation oncology at the University of Texas Southwestern Medical Center. "Patients expect that we are actively changing to improve radiation therapy treatment."

For example, Timmerman predicted that conventional radiation therapy, which requires six to eight weeks of daily treatments at much lower doses, will largely be replaced by hypofractionated radiation therapy, which delivers very potent, focused beams of radiation to tumors in five or fewer outpatient sessions of less than 30-60 minutes each. Hypofractionated radiation therapy might also offer a new way to improve survival in properly selected patients with emphysema by selectively causing scarring, or fibrosis, that allows more efficient breathing.

Dheerendra Prasad, M.D., director and associate professor of radiation and neurosurgery at Roswell Park Cancer Institute, said the increased desire of patients to enhance quality of life during brain cancer therapy will lead to widespread use of hypofractionated radiation to specifically target brain tumors – rather than irradiating the entire brain – to save normal brain tissue and preserve brain functions such as memory and fine motor control.

With these same advances in targeted radiation therapy, some radiation oncologists are beginning to deliver the entire course of radiation at the time of breast cancer surgery, which is the most efficient delivery of care.

For more information: www.elekta.com/future

Related Content

Study Unveils Blueprint for Treating Radiation-Resistant Brain Tumor

NIH-funded researchers showed how gliomas may be treated with radiation and drugs that block DNA repair. Image courtesy of Castro lab, Michigan Medicine, Ann Arbor

 

News | Radiation Therapy | February 19, 2019
February 19, 2019 — Researchers at the University of Michigan recently searched for new brain tumor treatments by exp
Videos | Radiation Therapy | February 15, 2019
ITN Associate Editor Jeff Zagoudis speaks with Vinai Gondi, M.D., director of research and CNS neuro-oncology at the
New Targeted Therapy for Recurrent Brain Tumors Implanted for First Time
News | Radiation Therapy | February 15, 2019
University of Minnesota Health (M Health) is the first in the United States to begin offering GammaTile Therapy, a new...
Canon Adds Radiation Therapy Package to Aquilion Prime, Lightning CT Systems
News | Computed Tomography (CT) | February 11, 2019
In the patient-centric world of radiation oncology, it is critical that computed tomography (CT) simulation is...
Elekta Unity MR-Linac Earns FDA Clearance
Technology | Image Guided Radiation Therapy (IGRT) | February 07, 2019
The Elekta Unity magnetic resonance radiation therapy (MR/RT) system recently received 510(k) premarket notification...
University of Oklahoma Cancer Center Begins First Proton Therapy Treatments
News | Proton Therapy | February 01, 2019
Home to the largest and most comprehensive radiation therapy program in Oklahoma, the Stephenson Cancer Center at OU (...
Stereotactic Radiotherapy Improves Long-Term Survival in Stage-IV Cancers
News | Stereotactic Body Radiation Therapy (SBRT) | January 31, 2019
The first report from a phase II, multi-center clinical trial indicates stereotactic radiation can extend long-term...
Philips Collaborates With MIM Software on Radiation Therapy Treatment Planning
News | Treatment Planning | January 31, 2019
January 31, 2019 — Philips announced a collaboration with imaging solutions provider MIM Software Inc.
Videos | Lung Cancer | January 29, 2019
Gregory Videtic, M.D., staff physician in radiation oncology at the Cleveland Clinic, and David Johnstone, M.D., prof
Southern Asia's First Proton Therapy Center Begins Treatments
News | Proton Therapy | January 28, 2019
IBA (Ion Beam Applications SA) announced the opening of the Apollo Proton Cancer Centre in Chennai, India, and the...